National Strategic Accounts,

Magnolia Medical Technologies has the unique opportunity for an Associate Vice President of National Strategic Accounts to join the Commercial team, reporting to the Vice President of Sales. This role will lead our efforts to acquire, maintain and expand relationships with Group Purchasing Organizations (GPOs), national Integrated Delivery Networks (IDNs), partnerships, regional collaboratives, buying groups and large, multi-location customers.

About Us

Magnolia Medical is a young company experiencing rapid growth as a commercial-stage medical device and healthcare solutions organization offering patented technology to address challenges that have long plagued our healthcare system. Our Steripath Initial Specimen Diversion Device for blood collection and contamination prevention has created a new standard of care for prevention of false positive blood cultures, the gold standard diagnostic test for sepsis. Steripath delivers significant clinical and cost savings benefits which have been extensively proven with large bodies of clinical data and peer-reviewed published studies. Based on this exceptional performance profile, we have an FDA-cleared indication for reducing blood culture contamination and uniquely provide a money-back Clinical Performance Guarantee for Steripath to our hospital customers.

With strong institutional investor backing, we offer highly committed and qualified candidates the opportunity to be a part of building a company dedicated to dramatically improving the accuracy of sepsis diagnostics to positively impact patient outcomes and hospital economics. We know our dynamic culture, innovative technology and achievement oriented team are solving some of the hardest problems that will create value for our customers and make us invaluable for this category in healthcare.

Key Responsibilities:

• Identifying and acquiring new business through thorough understanding Magnolia Medical's solution as well as our competitive advantage and evaluating it against market trends and industry needs.
• Developing and executing a sales strategy for new and existing accounts. Provide feedback to teams internally around customer value prop, competitive landscape, etc.
• Clear strategy and execution for closing deals with large national providers.
• Clear strategy and execution for distribution partners.
• Overseeing sales forecasting for strategic accounts and setting performance goals to align and manage sales pipeline to meet revenue goals.
• Cultivate, enhance and maintain corporate to corporate relationships with key decision makers, partners and strategic targets in prospective and existing accounts.
• Outline, prepare and deliver proposals addressing customers' technical, financial, and operational needs and concerns while achieving positive returns for the customer and the company.
• Taking a leadership role in the new contract development and contract re-sign process with accounts, customers and/or hospitals including the execution of final contracts from beginning to end (negotiation, execution, management).
• Develop and execute a cohesive GPO contracting strategy.
• Articulates the clinical and economic value proposition clearly, providing customers with an in depth understanding of what patient, clinical and financial benefits are associated with Magnolia Medical's solution.
• Establishing and maintaining customer and account communications and requirements ensuring solutions meet needs and stated goals of the customer, as well as Magnolia Medical Technologies.
• Provides information to senior leadership regarding competitive activity and emerging trends in the industry.
• Working collaboratively with sales leaders, sales teams, account management and clinical education in transitioning early-stage sales and evaluations from conception to implementation.
• Oversight on account procurement, MMT distribution processes and contractual events to protect the base business and continuously drive sales and profit growth.
• Other duties as assigned.

Knowledge, Experience, Education

• BS/BA
• Extensive sales success, sales management success, and high-level business to business success including proven experience with national account management across multiple geographies
• High level ability to build relationships with C-suite/owners/ decision maker
• Thorough understanding and experience with calling on GPOs, IDNs, etc.
• Demonstrated ability to build awareness of competitive products and activities, with an overall understanding of healthcare operations
• Excellent verbal and written communication skills, with the ability to develop and present comprehensive reports. Ability to have difficult conversations when warranted (internal and external)
• Ability to create customer relationships built on trust and to be perceived as a consummate professional that possesses the ability to deliver on commitments
• Demonstrated ability to synthesize facts and insights into concrete, actionable recommendations
• Industry legal and compliance knowledge
• Ability to travel up to 70%
• Local to a major metropolitan airport in the West (CA, TX, IL, etc.)

More about Magnolia Medical Technologies

Magnolia Medical Technologies develops, manufactures and markets innovative blood and bodily fluid collection devices to facilitate significant improvements in the accuracy, consistency and predictability of critical laboratory tests.

Dr. Richard Patton, the company's co-founder and Medical Director, invented and patented the Initial Specimen Diversion Technique (ISDT) and Initial Specimen Diversion Device (ISDD) for blood culture collection and contamination prevention, and authored the seminal peer-reviewed publication on this technique published in the Journal of Clinical Microbiology in 2010.

The company's flagship product, Steripath Initial Specimen Diversion Device for blood culture collection and contamination prevention, has been clinically proven in 17 clinical studies including 5 peer-reviewed publications to virtually eliminate the preventable error of blood culture contamination and false positive results for the diagnosis of Sepsis – delivering a reduction in false positives of up to 92% with 12-month sustained contamination rates as low as 0.2% and an average annualized cost savings of ~$1M.

Magnolia is establishing the new standard for blood culture integrity and sepsis testing accuracy with a mission to change national blood culture collection guidelines and contamination benchmarks.

The company has amassed an intellectual property portfolio including more than 70 issued method, apparatus and design patents with more than 50 additional patent applications pending. The total potential market for Magnolia's technology exceeds $2.0 billion annually.

Magnolia Medical is committed to the continued development and successful marketing of innovative products that will transform the way healthcare is practiced around the world. The company supports this effort by offering competitive compensation, incentive packages, benefits and career growth opportunities to the most qualified candidates in the marketplace. Magnolia Medical Technologies, Inc. is an equal opportunity employer.

For more information, visit magnolia-

• Must be willing to submit to a criminal background check upon offer of employment.

** As a condition of employment with Magnolia Medical Technologies, you are required to provide proof that you are fully vaccinated against COVID-19 or qualify for a reasonable accommodation.